139 related articles for article (PubMed ID: 18537570)
1. Targeting apoptosis to treat multiple sclerosis.
Hebb AL; Moore CS; Bhan V; Robertson GS
Curr Drug Discov Technol; 2008 Mar; 5(1):75-7. PubMed ID: 18537570
[TBL] [Abstract][Full Text] [Related]
2. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.
Hebb AL; Moore CS; Bhan V; Campbell T; Fisk JD; Robertson HA; Thorne M; Lacasse E; Holcik M; Gillard J; Crocker SJ; Robertson GS
Mult Scler; 2008 Jun; 14(5):577-94. PubMed ID: 18566024
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy.
Sharief MK; Noori MA; Zoukos Y
J Neuroimmunol; 2002 Aug; 129(1-2):224-31. PubMed ID: 12161039
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
Moore CS; Hebb AL; Robertson GS
J Neuroimmunol; 2008 Jan; 193(1-2):94-105. PubMed ID: 18055022
[TBL] [Abstract][Full Text] [Related]
5. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
Sharief MK; Semra YK
J Neuroimmunol; 2001 Oct; 119(2):350-7. PubMed ID: 11585639
[TBL] [Abstract][Full Text] [Related]
7. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2002 Jan; 122(1-2):159-66. PubMed ID: 11777555
[TBL] [Abstract][Full Text] [Related]
8. T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis.
Bahbouhi B; Pettré S; Berthelot L; Garcia A; Elong Ngono A; Degauque N; Michel L; Wiertlewski S; Lefrère F; Meyniel C; Delcroix C; Brouard S; Laplaud DA; Soulillou JP
Brain; 2010 Jun; 133(Pt 6):1622-36. PubMed ID: 20435630
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
[TBL] [Abstract][Full Text] [Related]
10. Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.
Holcík M
Expert Opin Ther Targets; 2004 Jun; 8(3):241-53. PubMed ID: 15161430
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
[TBL] [Abstract][Full Text] [Related]
12. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
13. Myelin regulates immune cell adhesion and motility.
Pool M; Niino M; Rambaldi I; Robson K; Bar-Or A; Fournier AE
Exp Neurol; 2009 Jun; 217(2):371-7. PubMed ID: 19328785
[TBL] [Abstract][Full Text] [Related]
14. Diminished myelin-specific T cell activation associated with increase in CTLA4 and Fas molecules in multiple sclerosis patients treated with IFN-beta.
Hallal-Longo DE; Mirandola SR; Oliveira EC; Farias AS; Pereira FG; Metze IL; Brandão CO; Ruocco HH; Damasceno BP; Santos LM
J Interferon Cytokine Res; 2007 Oct; 27(10):865-73. PubMed ID: 17970696
[TBL] [Abstract][Full Text] [Related]
15. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
16. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
Stuerzebecher S; Martin R
Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
Sharief MK; Semra YK
Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
[TBL] [Abstract][Full Text] [Related]
18. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
Stinissen P; Medaer R; Raus J
Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced cell death in T lymphocytes from multiple sclerosis patients.
Moreno M; Negrotto L; Río J; Moubarak R; Martín I; Bustamante MF; Comella JX; Vidal-Jordana A; Pérez-Boza J; Montalban X; Comabella M
J Neuroimmunol; 2014 Jul; 272(1-2):51-5. PubMed ID: 24793898
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions.
Zettl UK; Kuhlmann T; Brück W
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):202-8. PubMed ID: 9717185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
